First, Thank you Pierre77- I wasn't aware the HSBC account was an ADR holding tank.
Secondly, It's sort of ironic that the screwers (the BOD) might become the screwees:
I see the potential for class action in the future. There's no evidence that Sinclair knew ahead of time (wink), but there should be plenty of evidence that GK and the team were informed prior to the posting of the valuation report. The revelation re PBT2 never made it to the ASX or to FTI. ...And the report was dated Feb 26 2019, so the BOD had time to peruse the report prior to its dissemination. It appears they knowingly released a valuation report based on seriously incomplete/flawed data.
"High fives" all around as our BOD (minus Goslin) moves on to become part of the new BOD with their cushy "jobs" and remuneration...that is...until the lawyers/sharks show up. GK and crew don't have much of a defense. FTI will gladly throw our BOD to the wolves to absolve themselves from blame (though they might get a slap on the wrist for the incomplete DD) leaving the sharks to have a field day, while Sinclair is standing on dry land. "Oh dear, involved in "shady practices" must regrettably let our "new" BOD members go - as it wouldn't be appropriate to keep them around. Just like removing lice with a fine tooth comb, "Sorry guys - I know the deal was to keep you on, but out you go."
And the winner is...drum roll...David Sinclair!
Unfortunately, it doesn't do much for us, though Sinclair (minus some deadweight) might make things happen. PBT2 is still a serious contender and the other compounds might produce some lucrative results. There's still some potential here. I'm keeping some shares just in case...
My opinion only
PBT Price at posting:
3.8¢ Sentiment: Hold Disclosure: Held